A Conserved E7-derived Cytotoxic T Lymphocyte Epitope Expressed on Human Papillomavirus 16-transformed HLA-A2+ Epithelial Cancers
Open Access
- 1 September 2010
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 285 (38), 29608-29622
- https://doi.org/10.1074/jbc.m110.126722
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- NetMHCpan, a method for MHC class I binding prediction beyond humansImmunogenetics, 2008
- The IMGT/HLA databaseNucleic Acids Research, 2008
- An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial resultsVaccine, 2008
- Structural Analysis Reveals an Amyloid Form of the Human Papillomavirus Type 16 E1 ∧ E4 Protein and Provides a Molecular Basis for Its AccumulationJournal of Virology, 2008
- Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia IIIGynecologic Oncology, 2007
- HLA-DQB1*02–Restricted HPV-16 E7 Peptide–Specific CD4+ T-Cell Immune Responses Correlate with Regression of HPV-16–Associated High-Grade Squamous Intraepithelial LesionsClinical Cancer Research, 2007
- HLA Class I Binding Promiscuity of the CD8 T-Cell Epitopes of Human Papillomavirus Type 16 E6 ProteinJournal of Virology, 2007
- Prophylactic human papillomavirus vaccinesJCI Insight, 2006
- Against which human papillomavirus types shall we vaccinate and screen? the international perspectiveInternational Journal of Cancer, 2004
- Immune evasion in human papillomavirus-associated cervical cancerNature Reviews Cancer, 2002